Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer
Yoshinaga Okugawa(Mie University Hospital), Masato Kusunoki(Mie University), Tsunehiko Shigemori(Mie University), Hiroyuki Fujikawa(Hospital d'Igualada), Akira Yamamoto(Juntendo University), Takahito Kitajima(Mie University), Junichiro Hiro(Fujita Health University), Shozo Ide(Maizuru Municipal Hospital), Yuji Toiyama(Mie University), Koji Tanaka(Mie University), Susumu Saigusa(Mie University), Minàko Kobayashi(Mie University), Takeshi Yokoe(Mie University), Donald C. McMillan(Glasgow Royal Infirmary), Ajay Goel(City of Hope), Toshimitsu Araki(Mie University), Shigeyuki Yoshiyama(Mie University), Chikao Miki(Mie University), Masaki Ohi(Mie University), Hiromi Yasuda(Mie University), Yumiko Shirai
Cited by 298
Related Papers
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
|Gastroenterology|2015|814
Pathways of Colorectal Carcinogenesis
|Gastroenterology|2019|594
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
|British Journal of Cancer|2011|526
Molecular Classification and Correlates in Colorectal Cancer
|Journal of Molecular Diagnostics|2007|460
Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy
|Annals of Surgical Oncology|2009|324